HEADER DNA/ANTIBIOTIC 10-SEP-03 1UNJ TITLE CRYSTAL STRUCTURE OF A 7-AMINOACTINOMYCIN D COMPLEX WITH NON- TITLE 2 COMPLEMENTARY DNA COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5'-D(*TP*TP*AP*GP*BRU*TP)-3'; COMPND 3 CHAIN: A, B, C, D, G, H, I, J, M, N, O, P, S, T, U, V; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: 7-AMINO-ACTINOMYCIN D; COMPND 7 CHAIN: E, F, K, L, Q, R, W, X; COMPND 8 SYNONYM: DACTINOMYCIN; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 4 ORGANISM_TAXID: 32630; SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES; SOURCE 7 ORGANISM_SCIENTIFIC: STREPTOMYCES ANTIBIOTICUS; SOURCE 8 ORGANISM_TAXID: 1890 KEYWDS ACTINOMYCIN D, ACTINOMYCIN, ANTIBIOTIC, ANTI CANCER, ANTITUMOR, KEYWDS 2 CHROMOPHORE, DEPSIPEPTIDE, DNA-ANTIBIOTIC COMPLEX, FLUORESCENT KEYWDS 3 AGENT, HOOGSTEN BASE-PAIR EXPDTA X-RAY DIFFRACTION AUTHOR E.C.ALEXOPOULOS,R.KLEMENT,E.A.JARES-ERIJMAN,I.USON,T.M.JOVIN, AUTHOR 2 G.M.SHELDRICK REVDAT 13 16-OCT-24 1UNJ 1 REMARK REVDAT 12 10-JUL-24 1UNJ 1 COMPND SOURCE FORMUL LINK REVDAT 11 15-NOV-23 1UNJ 1 LINK ATOM REVDAT 10 23-OCT-19 1UNJ 1 SEQADV REVDAT 9 24-JUL-19 1UNJ 1 REMARK REVDAT 8 22-MAY-19 1UNJ 1 REMARK REVDAT 7 08-MAY-19 1UNJ 1 REMARK REVDAT 6 06-MAR-19 1UNJ 1 REMARK LINK REVDAT 5 20-JUL-11 1UNJ 1 TITLE REVDAT REMARK SEQADV REVDAT 4 13-JUL-11 1UNJ 1 VERSN REVDAT 3 24-FEB-09 1UNJ 1 VERSN REVDAT 2 06-APR-05 1UNJ 1 JRNL REVDAT 1 16-DEC-04 1UNJ 0 JRNL AUTH E.C.ALEXOPOULOS,E.A.JARES-ERIJMAN,T.M.JOVIN,R.KLEMENT, JRNL AUTH 2 R.MACHINEK,G.M.SHELDRICK,I.USON JRNL TITL CRYSTAL AND SOLUTION STRUCTURES OF 7-AMINO-ACTINOMYCIN D JRNL TITL 2 COMPLEXES WITH D(TTAGBRUT), D(TTAGTT) AND D(TTTAGTTT) JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 61 407 2005 JRNL REFN ISSN 0907-4449 JRNL PMID 15805595 JRNL DOI 10.1107/S090744490500082X REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : IN THIN SHELLS REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.276 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.316 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 577 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 11527 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.258 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.296 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 13.200 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 501 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 9358 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 728 REMARK 3 NUCLEIC ACID ATOMS : 1503 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 14 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2236.8 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 0 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 8996 REMARK 3 NUMBER OF RESTRAINTS : 17002 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 ANGLE DISTANCES (A) : 0.015 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.029 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.159 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.003 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.004 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.002 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1UNJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-SEP-03. REMARK 100 THE DEPOSITION ID IS D_1290013477. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUL-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.60 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : BW7A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9050,0.9196,0.9204 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11527 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 10.15 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.5700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.3 REMARK 200 DATA REDUNDANCY IN SHELL : 9.37 REMARK 200 R MERGE FOR SHELL (I) : 0.48000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.270 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELXD REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NA.CITRATE PH 5.6, REMARK 280 NA.ACETATE,(NH4)2SO4,HANGING DROP,T 293K, PH 5.60, VAPOR REMARK 280 DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 72.26667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 36.13333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 36.13333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 72.26667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DODECAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F, G, H, I, J, REMARK 350 AND CHAINS: K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DODECAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: M, N, O, P, Q, R, S, T, U, V, REMARK 350 AND CHAINS: W, X REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ACTINOMYCIN D IS A BICYCLIC PEPTIDE, A MEMBER OF THE REMARK 400 ACTINOMYCIN FAMILY. REMARK 400 HERE, ACTINOMYCIN D IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: ACTINOMYCIN D REMARK 400 CHAIN: E, F, K, L, Q, R, W, X REMARK 400 COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 11 REMARK 400 DESCRIPTION: ACTINOMYCIN D CONSISTS OF TWO PENTAMER REMARK 400 RINGS LINKED BY THE CHROMOPHORE (PX1) REMARK 400 THE CHROMOPHORE PX1 IS A MODIFIED PXZ WITH REMARK 400 C-NH2 REPLACING C-H IN POSITION 7 OF THE REMARK 400 PHENOXAZONE RING. REMARK 400 REMARK 400 THE 7-AMINOACTINOMYCIN IS POLYPEPTIDE, A MEMBER OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: 7-AMINOACTINOMYCIN REMARK 400 CHAIN: E, F, K, L, Q, R, W, X REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: ACTINOMYCIN D CONSISTS OF TWO PENTAMER RINGS LINKED REMARK 400 BY THE CHROMOPHORE (PX1) THE CHROMOPHORE PX1 IS A REMARK 400 MODIFIED PXZ WITH C-NH2 REPLACING C-H IN POSITION 7 REMARK 400 OF THE PHENOXAZONE RING. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 DT A 1 REMARK 465 DT B 1 REMARK 465 DT B 2 REMARK 465 DT C 1 REMARK 465 DT D 1 REMARK 465 DT G 1 REMARK 465 DT H 1 REMARK 465 DT H 2 REMARK 465 DT I 1 REMARK 465 DT J 1 REMARK 465 DT M 1 REMARK 465 DT N 1 REMARK 465 DT O 1 REMARK 465 DT P 1 REMARK 465 DT S 1 REMARK 465 DT T 1 REMARK 465 DT U 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 DT B 6 O3' REMARK 470 DT C 6 C5' C4' O4' C3' O3' C2' C1' REMARK 470 DT C 6 N1 C2 O2 N3 C4 O4 C5 REMARK 470 DT C 6 C7 C6 REMARK 470 DT G 2 P OP1 OP2 O5' REMARK 470 DT H 6 O3' REMARK 470 DT J 2 P OP1 OP2 O5' REMARK 470 DT N 2 P OP1 OP2 O5' C5' C4' O4' REMARK 470 DT N 2 C3' C2' C1' N1 C2 O2 N3 REMARK 470 DT N 2 C4 O4 C5 C7 C6 REMARK 470 DT T 2 P OP1 OP2 O5' C5' C4' O4' REMARK 470 DT T 2 C3' C2' C1' N1 C2 O2 N3 REMARK 470 DT T 2 C4 O4 C5 C7 C6 REMARK 470 DT T 6 O3' REMARK 470 DT U 2 P OP1 OP2 O5' REMARK 470 DT V 1 O5' C5' REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O4 DT I 2 N6 DA J 3 4466 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 DA B 3 O4' - C1' - N9 ANGL. DEV. = -4.4 DEGREES REMARK 500 DT C 2 O4' - C1' - N1 ANGL. DEV. = 1.8 DEGREES REMARK 500 DA N 3 O4' - C1' - N9 ANGL. DEV. = -4.5 DEGREES REMARK 500 DT O 2 O4' - C1' - N1 ANGL. DEV. = 3.3 DEGREES REMARK 500 DT P 6 O4' - C4' - C3' ANGL. DEV. = -2.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 SAR Q 10 -10.31 REMARK 500 THR R 1 -10.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF 7-AMINO-ACTINOMYCIN REMARK 800 D REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF 7-AMINO-ACTINOMYCIN REMARK 800 D REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN K OF 7-AMINO-ACTINOMYCIN REMARK 800 D REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN L OF 7-AMINO-ACTINOMYCIN REMARK 800 D REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN Q OF 7-AMINO-ACTINOMYCIN REMARK 800 D REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN R OF 7-AMINO-ACTINOMYCIN REMARK 800 D REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN W OF 7-AMINO-ACTINOMYCIN REMARK 800 D REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN X OF 7-AMINO-ACTINOMYCIN REMARK 800 D REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A7Z RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN Z3 REMARK 900 RELATED ID: 209D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF N8-ACTINOMYCIN D COMPLEXED WITH D(GAAGCTTC)2 REMARK 900 RELATED ID: 1UNM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 7-AMINOACTINOMYCIN D COMPLEXED WITH NON- REMARK 900 COMPLEMENTARY DNA REMARK 900 RELATED ID: 1I3W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (CGATCGATCG)2 REMARK 900 RELATED ID: 1A7Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D REMARK 900 RELATED ID: 1FJA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (AAGCGCTT)2 REMARK 900 RELATED ID: 173D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 2D55 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 1DSC RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 1L1V RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF ACTNIOMYCIN D COMPLEXED WITH MISMATCHED DNA REMARK 900 (GTCACCGAC) REMARK 900 RELATED ID: 316D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF F8-ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 1DSD RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GATGCTTC)2 REMARK 900 RELATED ID: 1MNV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (ATGCTGCAT)2 REMARK 900 RELATED ID: 1OVF RELATED DB: PDB REMARK 900 SOLUTIOM STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (CCGTTTTGTGG) REMARK 900 2 REMARK 900 RELATED ID: 1QFI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN X2 DBREF 1UNJ A 1 6 PDB 1UNJ 1UNJ 1 6 DBREF 1UNJ B 1 6 PDB 1UNJ 1UNJ 1 6 DBREF 1UNJ C 1 6 PDB 1UNJ 1UNJ 1 6 DBREF 1UNJ D 1 6 PDB 1UNJ 1UNJ 1 6 DBREF 1UNJ G 1 6 PDB 1UNJ 1UNJ 1 6 DBREF 1UNJ H 1 6 PDB 1UNJ 1UNJ 1 6 DBREF 1UNJ I 1 6 PDB 1UNJ 1UNJ 1 6 DBREF 1UNJ J 1 6 PDB 1UNJ 1UNJ 1 6 DBREF 1UNJ M 1 6 PDB 1UNJ 1UNJ 1 6 DBREF 1UNJ N 1 6 PDB 1UNJ 1UNJ 1 6 DBREF 1UNJ O 1 6 PDB 1UNJ 1UNJ 1 6 DBREF 1UNJ P 1 6 PDB 1UNJ 1UNJ 1 6 DBREF 1UNJ S 1 6 PDB 1UNJ 1UNJ 1 6 DBREF 1UNJ T 1 6 PDB 1UNJ 1UNJ 1 6 DBREF 1UNJ U 1 6 PDB 1UNJ 1UNJ 1 6 DBREF 1UNJ V 1 6 PDB 1UNJ 1UNJ 1 6 DBREF 1UNJ E 1 11 NOR NOR00228 NOR00228 1 11 DBREF 1UNJ F 1 11 NOR NOR00228 NOR00228 1 11 DBREF 1UNJ K 1 11 NOR NOR00228 NOR00228 1 11 DBREF 1UNJ L 1 11 NOR NOR00228 NOR00228 1 11 DBREF 1UNJ Q 1 11 NOR NOR00228 NOR00228 1 11 DBREF 1UNJ R 1 11 NOR NOR00228 NOR00228 1 11 DBREF 1UNJ W 1 11 NOR NOR00228 NOR00228 1 11 DBREF 1UNJ X 1 11 NOR NOR00228 NOR00228 1 11 SEQADV 1UNJ PX1 E 6 NOR NOR00228 PXZ 6 CHROMOPHORE SEQADV 1UNJ PX1 F 6 NOR NOR00228 PXZ 6 CHROMOPHORE SEQADV 1UNJ PX1 K 6 NOR NOR00228 PXZ 6 CHROMOPHORE SEQADV 1UNJ PX1 L 6 NOR NOR00228 PXZ 6 CHROMOPHORE SEQADV 1UNJ PX1 Q 6 NOR NOR00228 PXZ 6 CHROMOPHORE SEQADV 1UNJ PX1 R 6 NOR NOR00228 PXZ 6 CHROMOPHORE SEQADV 1UNJ PX1 W 6 NOR NOR00228 PXZ 6 CHROMOPHORE SEQADV 1UNJ PX1 X 6 NOR NOR00228 PXZ 6 CHROMOPHORE SEQRES 1 A 6 DT DT DA DG BRU DT SEQRES 1 B 6 DT DT DA DG BRU DT SEQRES 1 C 6 DT DT DA DG BRU DT SEQRES 1 D 6 DT DT DA DG BRU DT SEQRES 1 E 11 THR DVA PRO SAR MVA PX1 THR DVA PRO SAR MVA SEQRES 1 F 11 THR DVA PRO SAR MVA PX1 THR DVA PRO SAR MVA SEQRES 1 G 6 DT DT DA DG BRU DT SEQRES 1 H 6 DT DT DA DG BRU DT SEQRES 1 I 6 DT DT DA DG BRU DT SEQRES 1 J 6 DT DT DA DG BRU DT SEQRES 1 K 11 THR DVA PRO SAR MVA PX1 THR DVA PRO SAR MVA SEQRES 1 L 11 THR DVA PRO SAR MVA PX1 THR DVA PRO SAR MVA SEQRES 1 M 6 DT DT DA DG BRU DT SEQRES 1 N 6 DT DT DA DG BRU DT SEQRES 1 O 6 DT DT DA DG BRU DT SEQRES 1 P 6 DT DT DA DG BRU DT SEQRES 1 Q 11 THR DVA PRO SAR MVA PX1 THR DVA PRO SAR MVA SEQRES 1 R 11 THR DVA PRO SAR MVA PX1 THR DVA PRO SAR MVA SEQRES 1 S 6 DT DT DA DG BRU DT SEQRES 1 T 6 DT DT DA DG BRU DT SEQRES 1 U 6 DT DT DA DG BRU DT SEQRES 1 V 6 DT DT DA DG BRU DT SEQRES 1 W 11 THR DVA PRO SAR MVA PX1 THR DVA PRO SAR MVA SEQRES 1 X 11 THR DVA PRO SAR MVA PX1 THR DVA PRO SAR MVA MODRES 1UNJ BRU A 5 DU MODRES 1UNJ BRU B 5 DU MODRES 1UNJ BRU C 5 DU MODRES 1UNJ BRU D 5 DU MODRES 1UNJ SAR E 4 GLY SARCOSINE MODRES 1UNJ MVA E 5 VAL N-METHYLVALINE MODRES 1UNJ SAR E 10 GLY SARCOSINE MODRES 1UNJ MVA E 11 VAL N-METHYLVALINE MODRES 1UNJ SAR F 4 GLY SARCOSINE MODRES 1UNJ MVA F 5 VAL N-METHYLVALINE MODRES 1UNJ SAR F 10 GLY SARCOSINE MODRES 1UNJ MVA F 11 VAL N-METHYLVALINE MODRES 1UNJ BRU G 5 DU MODRES 1UNJ BRU H 5 DU MODRES 1UNJ BRU I 5 DU MODRES 1UNJ BRU J 5 DU MODRES 1UNJ SAR K 4 GLY SARCOSINE MODRES 1UNJ MVA K 5 VAL N-METHYLVALINE MODRES 1UNJ SAR K 10 GLY SARCOSINE MODRES 1UNJ MVA K 11 VAL N-METHYLVALINE MODRES 1UNJ SAR L 4 GLY SARCOSINE MODRES 1UNJ MVA L 5 VAL N-METHYLVALINE MODRES 1UNJ SAR L 10 GLY SARCOSINE MODRES 1UNJ MVA L 11 VAL N-METHYLVALINE MODRES 1UNJ BRU M 5 DU MODRES 1UNJ BRU N 5 DU MODRES 1UNJ BRU O 5 DU MODRES 1UNJ BRU P 5 DU MODRES 1UNJ SAR Q 4 GLY SARCOSINE MODRES 1UNJ MVA Q 5 VAL N-METHYLVALINE MODRES 1UNJ SAR Q 10 GLY SARCOSINE MODRES 1UNJ MVA Q 11 VAL N-METHYLVALINE MODRES 1UNJ SAR R 4 GLY SARCOSINE MODRES 1UNJ MVA R 5 VAL N-METHYLVALINE MODRES 1UNJ SAR R 10 GLY SARCOSINE MODRES 1UNJ MVA R 11 VAL N-METHYLVALINE MODRES 1UNJ BRU S 5 DU MODRES 1UNJ BRU T 5 DU MODRES 1UNJ BRU U 5 DU MODRES 1UNJ BRU V 5 DU MODRES 1UNJ SAR W 4 GLY SARCOSINE MODRES 1UNJ MVA W 5 VAL N-METHYLVALINE MODRES 1UNJ SAR W 10 GLY SARCOSINE MODRES 1UNJ MVA W 11 VAL N-METHYLVALINE MODRES 1UNJ SAR X 4 GLY SARCOSINE MODRES 1UNJ MVA X 5 VAL N-METHYLVALINE MODRES 1UNJ SAR X 10 GLY SARCOSINE MODRES 1UNJ MVA X 11 VAL N-METHYLVALINE HET BRU A 5 20 HET BRU B 5 20 HET BRU C 5 20 HET BRU D 5 20 HET DVA E 2 7 HET SAR E 4 5 HET MVA E 5 8 HET PX1 E 6 23 HET DVA E 8 7 HET SAR E 10 5 HET MVA E 11 8 HET DVA F 2 7 HET SAR F 4 5 HET MVA F 5 8 HET PX1 F 6 23 HET DVA F 8 7 HET SAR F 10 5 HET MVA F 11 8 HET BRU G 5 20 HET BRU H 5 20 HET BRU I 5 20 HET BRU J 5 20 HET DVA K 2 7 HET SAR K 4 5 HET MVA K 5 8 HET PX1 K 6 23 HET DVA K 8 7 HET SAR K 10 5 HET MVA K 11 8 HET DVA L 2 7 HET SAR L 4 5 HET MVA L 5 8 HET PX1 L 6 23 HET DVA L 8 7 HET SAR L 10 5 HET MVA L 11 8 HET BRU M 5 20 HET BRU N 5 20 HET BRU O 5 20 HET BRU P 5 20 HET DVA Q 2 7 HET SAR Q 4 5 HET MVA Q 5 8 HET PX1 Q 6 23 HET DVA Q 8 7 HET SAR Q 10 5 HET MVA Q 11 8 HET DVA R 2 7 HET SAR R 4 5 HET MVA R 5 8 HET PX1 R 6 23 HET DVA R 8 7 HET SAR R 10 5 HET MVA R 11 8 HET BRU S 5 20 HET BRU T 5 20 HET BRU U 5 20 HET BRU V 5 20 HET DVA W 2 7 HET SAR W 4 5 HET MVA W 5 8 HET PX1 W 6 23 HET DVA W 8 7 HET SAR W 10 5 HET MVA W 11 8 HET DVA X 2 7 HET SAR X 4 5 HET MVA X 5 8 HET PX1 X 6 23 HET DVA X 8 7 HET SAR X 10 5 HET MVA X 11 8 HETNAM BRU 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE HETNAM DVA D-VALINE HETNAM SAR SARCOSINE HETNAM MVA N-METHYLVALINE HETNAM PX1 (1Z)-7-AMINO-1-(HYDROXYMETHYLENE)-2-IMINO-4,6-DIMETHYL- HETNAM 2 PX1 3-OXO-2,3-DIHYDRO-1H-PHENOXAZINE-9-CARBALDEHYDE FORMUL 1 BRU 16(C9 H12 BR N2 O8 P) FORMUL 5 DVA 16(C5 H11 N O2) FORMUL 5 SAR 16(C3 H7 N O2) FORMUL 5 MVA 16(C6 H13 N O2) FORMUL 5 PX1 8(C16 H13 N3 O6) FORMUL 25 HOH *14(H2 O) LINK O3' DG A 4 P BRU A 5 1555 1555 1.61 LINK O3' BRU A 5 P DT A 6 1555 1555 1.61 LINK O3' DG B 4 P BRU B 5 1555 1555 1.61 LINK O3' BRU B 5 P DT B 6 1555 1555 1.61 LINK O3' DG C 4 P BRU C 5 1555 1555 1.62 LINK O3' BRU C 5 P DT C 6 1555 1555 1.61 LINK O3' DG D 4 P BRU D 5 1555 1555 1.62 LINK O3' BRU D 5 P DT D 6 1555 1555 1.61 LINK C THR E 1 N DVA E 2 1555 1555 1.34 LINK OG1 THR E 1 C MVA E 5 1555 1555 1.35 LINK N THR E 1 C0 PX1 E 6 1555 1555 1.33 LINK C DVA E 2 N PRO E 3 1555 1555 1.33 LINK C PRO E 3 N SAR E 4 1555 1555 1.32 LINK C SAR E 4 N MVA E 5 1555 1555 1.33 LINK C0' PX1 E 6 N THR E 7 1555 1555 1.33 LINK C THR E 7 N DVA E 8 1555 1555 1.33 LINK OG1 THR E 7 C MVA E 11 1555 1555 1.35 LINK C DVA E 8 N PRO E 9 1555 1555 1.33 LINK C PRO E 9 N SAR E 10 1555 1555 1.32 LINK C SAR E 10 N MVA E 11 1555 1555 1.34 LINK C THR F 1 N DVA F 2 1555 1555 1.34 LINK OG1 THR F 1 C MVA F 5 1555 1555 1.35 LINK N THR F 1 C0 PX1 F 6 1555 1555 1.34 LINK C DVA F 2 N PRO F 3 1555 1555 1.33 LINK C PRO F 3 N SAR F 4 1555 1555 1.33 LINK C SAR F 4 N MVA F 5 1555 1555 1.33 LINK C0' PX1 F 6 N THR F 7 1555 1555 1.33 LINK C THR F 7 N DVA F 8 1555 1555 1.33 LINK OG1 THR F 7 C MVA F 11 1555 1555 1.36 LINK C DVA F 8 N PRO F 9 1555 1555 1.33 LINK C PRO F 9 N SAR F 10 1555 1555 1.33 LINK C SAR F 10 N MVA F 11 1555 1555 1.33 LINK O3' DG G 4 P BRU G 5 1555 1555 1.60 LINK O3' BRU G 5 P DT G 6 1555 1555 1.62 LINK O3' DG H 4 P BRU H 5 1555 1555 1.60 LINK O3' BRU H 5 P DT H 6 1555 1555 1.62 LINK O3' DG I 4 P BRU I 5 1555 1555 1.61 LINK O3' BRU I 5 P DT I 6 1555 1555 1.61 LINK O3' DG J 4 P BRU J 5 1555 1555 1.61 LINK O3' BRU J 5 P DT J 6 1555 1555 1.62 LINK C THR K 1 N DVA K 2 1555 1555 1.34 LINK OG1 THR K 1 C MVA K 5 1555 1555 1.35 LINK N THR K 1 C0 PX1 K 6 1555 1555 1.34 LINK C DVA K 2 N PRO K 3 1555 1555 1.33 LINK C PRO K 3 N SAR K 4 1555 1555 1.32 LINK C SAR K 4 N MVA K 5 1555 1555 1.33 LINK C0' PX1 K 6 N THR K 7 1555 1555 1.33 LINK C THR K 7 N DVA K 8 1555 1555 1.34 LINK OG1 THR K 7 C MVA K 11 1555 1555 1.34 LINK C DVA K 8 N PRO K 9 1555 1555 1.33 LINK C PRO K 9 N SAR K 10 1555 1555 1.32 LINK C SAR K 10 N MVA K 11 1555 1555 1.33 LINK C THR L 1 N DVA L 2 1555 1555 1.33 LINK OG1 THR L 1 C MVA L 5 1555 1555 1.35 LINK N THR L 1 C0 PX1 L 6 1555 1555 1.33 LINK C DVA L 2 N PRO L 3 1555 1555 1.33 LINK C PRO L 3 N SAR L 4 1555 1555 1.33 LINK C SAR L 4 N MVA L 5 1555 1555 1.33 LINK C0' PX1 L 6 N THR L 7 1555 1555 1.32 LINK C THR L 7 N DVA L 8 1555 1555 1.34 LINK OG1 THR L 7 C MVA L 11 1555 1555 1.35 LINK C DVA L 8 N PRO L 9 1555 1555 1.33 LINK C PRO L 9 N SAR L 10 1555 1555 1.33 LINK C SAR L 10 N MVA L 11 1555 1555 1.33 LINK O3' DG M 4 P BRU M 5 1555 1555 1.61 LINK O3' BRU M 5 P DT M 6 1555 1555 1.61 LINK O3' DG N 4 P BRU N 5 1555 1555 1.60 LINK O3' BRU N 5 P DT N 6 1555 1555 1.61 LINK O3' DG O 4 P BRU O 5 1555 1555 1.61 LINK O3' BRU O 5 P DT O 6 1555 1555 1.60 LINK O3' DG P 4 P BRU P 5 1555 1555 1.61 LINK O3' BRU P 5 P DT P 6 1555 1555 1.61 LINK C THR Q 1 N DVA Q 2 1555 1555 1.34 LINK OG1 THR Q 1 C MVA Q 5 1555 1555 1.35 LINK N THR Q 1 C0 PX1 Q 6 1555 1555 1.33 LINK C DVA Q 2 N PRO Q 3 1555 1555 1.33 LINK C PRO Q 3 N SAR Q 4 1555 1555 1.32 LINK C SAR Q 4 N MVA Q 5 1555 1555 1.33 LINK C0' PX1 Q 6 N THR Q 7 1555 1555 1.33 LINK C THR Q 7 N DVA Q 8 1555 1555 1.33 LINK OG1 THR Q 7 C MVA Q 11 1555 1555 1.34 LINK C DVA Q 8 N PRO Q 9 1555 1555 1.33 LINK C PRO Q 9 N SAR Q 10 1555 1555 1.33 LINK C SAR Q 10 N MVA Q 11 1555 1555 1.34 LINK C THR R 1 N DVA R 2 1555 1555 1.34 LINK OG1 THR R 1 C MVA R 5 1555 1555 1.35 LINK N THR R 1 C0 PX1 R 6 1555 1555 1.33 LINK C DVA R 2 N PRO R 3 1555 1555 1.33 LINK C PRO R 3 N SAR R 4 1555 1555 1.33 LINK C SAR R 4 N MVA R 5 1555 1555 1.33 LINK C0' PX1 R 6 N THR R 7 1555 1555 1.33 LINK C THR R 7 N DVA R 8 1555 1555 1.33 LINK OG1 THR R 7 C MVA R 11 1555 1555 1.35 LINK C DVA R 8 N PRO R 9 1555 1555 1.32 LINK C PRO R 9 N SAR R 10 1555 1555 1.33 LINK C SAR R 10 N MVA R 11 1555 1555 1.34 LINK O3' DG S 4 P BRU S 5 1555 1555 1.60 LINK O3' BRU S 5 P DT S 6 1555 1555 1.61 LINK O3' DG T 4 P BRU T 5 1555 1555 1.61 LINK O3' BRU T 5 P DT T 6 1555 1555 1.61 LINK O3' DG U 4 P BRU U 5 1555 1555 1.61 LINK O3' BRU U 5 P DT U 6 1555 1555 1.61 LINK O3' DG V 4 P BRU V 5 1555 1555 1.61 LINK O3' BRU V 5 P DT V 6 1555 1555 1.61 LINK C THR W 1 N DVA W 2 1555 1555 1.34 LINK OG1 THR W 1 C MVA W 5 1555 1555 1.35 LINK N THR W 1 C0 PX1 W 6 1555 1555 1.33 LINK C DVA W 2 N PRO W 3 1555 1555 1.33 LINK C PRO W 3 N SAR W 4 1555 1555 1.32 LINK C SAR W 4 N MVA W 5 1555 1555 1.33 LINK C0' PX1 W 6 N THR W 7 1555 1555 1.33 LINK C THR W 7 N DVA W 8 1555 1555 1.33 LINK OG1 THR W 7 C MVA W 11 1555 1555 1.35 LINK C DVA W 8 N PRO W 9 1555 1555 1.32 LINK C PRO W 9 N SAR W 10 1555 1555 1.32 LINK C SAR W 10 N MVA W 11 1555 1555 1.34 LINK C THR X 1 N DVA X 2 1555 1555 1.34 LINK OG1 THR X 1 C MVA X 5 1555 1555 1.35 LINK N THR X 1 C0 PX1 X 6 1555 1555 1.34 LINK C DVA X 2 N PRO X 3 1555 1555 1.33 LINK C PRO X 3 N SAR X 4 1555 1555 1.33 LINK C SAR X 4 N MVA X 5 1555 1555 1.33 LINK C0' PX1 X 6 N THR X 7 1555 1555 1.33 LINK C THR X 7 N DVA X 8 1555 1555 1.33 LINK OG1 THR X 7 C MVA X 11 1555 1555 1.34 LINK C DVA X 8 N PRO X 9 1555 1555 1.33 LINK C PRO X 9 N SAR X 10 1555 1555 1.32 LINK C SAR X 10 N MVA X 11 1555 1555 1.33 CISPEP 1 DVA E 2 PRO E 3 0 13.05 CISPEP 2 PRO E 3 SAR E 4 0 -1.26 CISPEP 3 DVA E 8 PRO E 9 0 3.98 CISPEP 4 PRO E 9 SAR E 10 0 -10.56 CISPEP 5 DVA F 2 PRO F 3 0 8.76 CISPEP 6 PRO F 3 SAR F 4 0 -3.41 CISPEP 7 DVA F 8 PRO F 9 0 7.29 CISPEP 8 PRO F 9 SAR F 10 0 5.00 CISPEP 9 DVA K 2 PRO K 3 0 9.46 CISPEP 10 PRO K 3 SAR K 4 0 1.73 CISPEP 11 DVA K 8 PRO K 9 0 4.94 CISPEP 12 PRO K 9 SAR K 10 0 -8.31 CISPEP 13 DVA L 2 PRO L 3 0 7.85 CISPEP 14 PRO L 3 SAR L 4 0 -4.78 CISPEP 15 DVA L 8 PRO L 9 0 5.59 CISPEP 16 PRO L 9 SAR L 10 0 6.88 CISPEP 17 DVA Q 2 PRO Q 3 0 5.71 CISPEP 18 PRO Q 3 SAR Q 4 0 -3.66 CISPEP 19 DVA Q 8 PRO Q 9 0 4.41 CISPEP 20 PRO Q 9 SAR Q 10 0 -5.47 CISPEP 21 DVA R 2 PRO R 3 0 10.29 CISPEP 22 PRO R 3 SAR R 4 0 -7.25 CISPEP 23 DVA R 8 PRO R 9 0 4.04 CISPEP 24 PRO R 9 SAR R 10 0 5.67 CISPEP 25 DVA W 2 PRO W 3 0 5.92 CISPEP 26 PRO W 3 SAR W 4 0 0.89 CISPEP 27 DVA W 8 PRO W 9 0 7.99 CISPEP 28 PRO W 9 SAR W 10 0 -7.72 CISPEP 29 DVA X 2 PRO X 3 0 12.14 CISPEP 30 PRO X 3 SAR X 4 0 -12.28 CISPEP 31 DVA X 8 PRO X 9 0 5.42 CISPEP 32 PRO X 9 SAR X 10 0 4.72 SITE 1 AC1 11 DA A 3 DG A 4 BRU A 5 DT A 6 SITE 2 AC1 11 DA C 3 DG C 4 BRU C 5 DT H 6 SITE 3 AC1 11 DT J 2 BRU T 5 DT V 1 SITE 1 AC2 8 DG B 4 BRU B 5 DA D 3 DG D 4 SITE 2 AC2 8 BRU D 5 DT D 6 DT G 2 DA G 3 SITE 1 AC3 10 DT B 6 DT D 2 DA G 3 DG G 4 SITE 2 AC3 10 BRU G 5 DT G 6 DA I 3 DG I 4 SITE 3 AC3 10 BRU I 5 DVA L 2 SITE 1 AC4 9 DT A 2 DA A 3 DG H 4 BRU H 5 SITE 2 AC4 9 DA J 3 DG J 4 BRU J 5 DT J 6 SITE 3 AC4 9 DVA K 8 SITE 1 AC5 12 DA M 3 DG M 4 BRU M 5 DT M 6 SITE 2 AC5 12 DG O 4 BRU O 5 HOH Q2001 DVA R 2 SITE 3 AC5 12 SAR R 4 DVA R 8 DT T 6 DT V 2 SITE 1 AC6 11 DA N 3 DG N 4 BRU N 5 DA P 3 SITE 2 AC6 11 DG P 4 BRU P 5 DT P 6 DVA Q 2 SITE 3 AC6 11 DVA Q 8 DT S 2 DA S 3 SITE 1 AC7 10 DT N 6 DT P 2 DA S 3 DG S 4 SITE 2 AC7 10 BRU S 5 DT S 6 DG U 4 BRU U 5 SITE 3 AC7 10 HOH W2001 DVA X 2 SITE 1 AC8 12 DT M 2 DA M 3 DT S 6 DA T 3 SITE 2 AC8 12 DG T 4 BRU T 5 DA V 3 DG V 4 SITE 3 AC8 12 BRU V 5 DT V 6 DVA W 2 DVA W 8 CRYST1 71.222 71.222 108.400 90.00 90.00 120.00 P 32 2 1 96 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014041 0.008106 0.000000 0.00000 SCALE2 0.000000 0.016213 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009225 0.00000